Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Data is Dominating Wall Street

Host TC Riley kicks off this installment of Diving Into Data, with a deep-dive into the recent data-centric boom on Wall Street. “There’s a data dominance going on. There’s a lot more data related things going on in the stock market than I think we’ve traditionally seen, especially as it relates to the companies…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Data is Dominating Wall Street

Host TC Riley kicks off this installment of Diving Into Data, with a deep-dive into the recent data-centric boom on Wall Street. “There’s a data dominance going on. There’s a lot more data related things going on in the stock market than I think we’ve traditionally seen, especially as it relates to the companies themselves,” he said.

Snowflake and JFrog are two of the data companies to go under the magnifying glass. Snowflake is a cloud-based data-warehousing company that decouples storage and computation functions, which basically translates into a more easily controlled relationship between user expectations and costs. JFrog, on the other hand, is a DevOps platform that’s based in cloud functionality. Because of its cloud-based nature, the entire platform is easily customized and facilitates faster software releases.

TC pointed out that this data boom has indications for the future, saying “It’s interesting to see so many data companies that have these huge offerings. I think it points toward more and more people buying into the overall value of data long-term and where the business world is heading.”

On the topic of data companies, TC also talked about the challenges, and opportunities, of data in the healthcare industry. There are a lot of considerations that need to be undertaken in terms of privacy and possible misuse of patient information by, say, insurance companies when it comes to healthcare data, and TC mused about the potential benefits for the good of everyone in the future. “There is an opportunity to transform the way we think about healthcare data, and there’s not a perfect solution here,” he said.

To wrap things up, TC touched on how data could be used to prevent veteran suicides by transitioning from a bottom-up model that utilizes data gathered after tragic incidents to a top-down model that can identify triggers and conditions and preemptively stop the tragedy from happening at all. “I think it’s something we owe our veterans,” said TC.

Catch up on all episodes of Diving Into Data!

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512